Harshamitra Oncology Private Limited

Harshamitra Oncology Private Limited - healthcare in Tiruchirappalli, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74999TN2014PTC095975 Incorporated 30 May 2014 ROC Chennai HQ Tiruchirappalli, Tamil Nadu, India
Active Private Limited Company healthcare
Revenue · FY 2024
₹8.83 Cr
▲ 58% YoY
Net loss · FY 2024
₹17.88 Lakh
Net margin -2%
EBITDA · FY 2024
₹2.48 Cr
EBITDA margin 28.1%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.68 Cr
Issued & subscribed
Open charges
₹13.29 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
23
Provident fund records

About Harshamitra Oncology Private Limited

Data last updated:

Harshamitra Oncology Private Limited is a private limited company based in Tiruchirappalli, Tamil Nadu, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 30 May 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2014PTC095975.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.68 Cr. It is led by directors Govindaraj Ganesan (Managing Director) and Sasipriya Ponniah (Managing Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Tiruchirappalli, Tamil Nadu.

As per the financials filed for FY 2024, the company reported a revenue of ₹8.83 Cr, a growth of 58% compared to the previous year. For the same year it recorded a net loss of ₹17.88 Lakh (net margin -2%) and EBITDA of ₹2.48 Cr (EBITDA margin 28.1%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years and 57% over five years.

The company has about 23 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹13.29 Cr on record. The company has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹8.4 Cr; the latest was in February 2020. Its 4 peer companies in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities) are compared by revenue, 2 larger and 2 smaller; the largest is Erode Cancer Centre Private Limited with revenue of ₹9.73 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hopltrichy.com.

Company details

CIN U74999TN2014PTC095975
Registration Number 095975
Incorporation Date 30 May 2014
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Harshamitra Oncology Private Limited's registered office is in Tiruchirappalli, Tamil Nadu. Its website is hopltrichy.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    101/4A Mathur Panchayat Road Junction, NH 45 B Trichy – Madurai Highway, Tiruchirappalli, Tamil Nadu, India – 620012
  • Industry
    Healthcare, Oncology Clinics & Cancer Treatment

To see the full contact details of Harshamitra Oncology Private Limited, buy the company report.

Comprehensive company report
Harshamitra Oncology Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Harshamitra Oncology is hospital and medical care. In detail, this covers hospital activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ1Hospital activities

To see the full business activity and turnover split of Harshamitra Oncology Private Limited, buy the company report.

Financials of Harshamitra Oncology Private Limited

FY 2024 filings available

Harshamitra Oncology Private Limited reported revenue of ₹8.83 Cr (up 58% YoY) for FY 2024.

Revenue · FY 2024
₹8.83 Cr ▲ 58%
Net loss · FY 2024
₹17.88 Lakh margin -2%
EBITDA · FY 2024
₹2.48 Cr margin 28.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 58%
3 years · compounded
▲ 54%
5 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 28%
5 years · compounded
▲ 56%

Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 58% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.48 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹17.88 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin28.1%
Net Profit Margin-2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Harshamitra Oncology Private Limited, buy the company report.

Board of directors of Harshamitra Oncology Private Limited

Harshamitra Oncology has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Govindaraj GanesanManaging Director30 May 201412 Years 5 MonthsCurrent
Sasipriya PonniahManaging Director30 May 201412 Years 5 MonthsCurrent

Peer comparison

Harshamitra Oncology Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Erode Cancer Centre Private Limited₹9.73 Cr (FY 2025)3.0%Erode, Tamil Nadu, India
Bridge Gap Lifesciences Private Limited₹9.29 Cr (FY 2024)9.0%Hyderabad, Telangana, India
Harshamitra Oncology Private Limitedthis company₹8.83 Cr (FY 2024)-₹17.88 Lakh-2%58.0%23Tiruchirappalli, Tamil Nadu, India
Karkinos Healthcare North East Private Limited₹8.58 Cr (FY 2025)96.0%Imphal East, Manipur, India
Babina Healthcare Private Limited₹7.62 Cr (FY 2025)81.0%Imphal, Manipur, India

To see the full peer comparison of Harshamitra Oncology Private Limited, buy the company report.

Auditor

Harshamitra Oncology Private Limited is audited by J MARTIN AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
J MARTIN AND ASSOCIATESFY 2023007078S

Shareholding

The shareholding of Harshamitra Oncology Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Harshamitra Oncology Private Limited, buy the company report.

Charges & borrowings

Open charges
₹13.29 Cr
Satisfied charges
None
Breakdown by lending institutions
Indian Bank₹8.29 Cr
Others₹5.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Sep 2023100775376Indian Bank₹1.06 CrOpen
23 Dec 2021100536215Indian Bank₹65.3 LakhOpen
08 Dec 2017100178364Indian Bank₹6.58 CrOpen
23 Dec 2016100068843Others₹5 CrOpen

To see the full charge records of Harshamitra Oncology Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Harshamitra Oncology Private Limited has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹8.4 Cr; the latest was in February 2020.

Total deals
4
Funding rounds
2
Rights issue
1
Secondary share transfer
1
Disclosed funding
₹8.4 Cr

Deals on record (3 of 4)

WhenDealAmountParties
Feb 2020Rights issue₹22.5 LakhInvestors: 2 individuals
Mar 2018Secondary share transferUndisclosedBuyer: IFCI VENTURE CAPITAL FUND LIMITED
Seller: IFCI Ventures
Nov 2016Funding round₹3.67 CrInvestors: IFCI Ventures, 2 individuals

To see the full deal history of Harshamitra Oncology Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Harshamitra Oncology Private Limited was last rated by Crisil on 12 Mar 2020.

Rating agencyRated onRating
Crisil12 Mar 2020

To see the full credit ratings and regulatory alerts of Harshamitra Oncology Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Harshamitra Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Harshamitra Oncology Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1
Employee growth
21.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2723
FY 2025-26
FY 2024-25
FY 2023-24

To see the full employee and EPFO history of Harshamitra Oncology Private Limited, buy the company report.

GST

No GST registration is on our record for Harshamitra Oncology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Harshamitra Oncology Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Govindaraj Ganesan was appointed as Managing Director on 30 May 2014.

AGM
Harshamitra Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Harshamitra Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Indian Bank amounted to Rs. 1.06 Cr with Charge ID 100775376 was registered on 04 Sep 2023.
Charges
A charge with Indian Bank amounted to Rs. 0.65 Cr with Charge ID 100536215 was registered on 23 Dec 2021.
Charges
A charge with Others of Rs. 5.00 Cr registered on 23 Dec 2016 with Charge ID 100068843 was modified on 09 Jan 2018.
Charges
A charge with Indian Bank amounted to Rs. 6.58 Cr with Charge ID 100178364 was registered on 08 Dec 2017.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100068843 was registered on 23 Dec 2016.
Appointed
Govindaraj Ganesan was appointed as Managing Director.
Appointed
Sasipriya Ponniah was appointed as Managing Director.
Incorporation
30 May 2014
Harshamitra Oncology Private Limited was registered on 30 May 2014 with Roc Chennai & aged 12 years 5 months as per MCA records.

Frequently asked questions

Harshamitra Oncology is an active private limited company based in Tiruchirappalli, Tamil Nadu, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 30 May 2014 (12+ years old) and is registered under CIN U74999TN2014PTC095975.

Harshamitra Oncology has 2 current directors:

The latest financial statements of Harshamitra Oncology on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Harshamitra Oncology is U74999TN2014PTC095975. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Harshamitra Oncology was incorporated on 30 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.

Harshamitra Oncology has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹8.4 Cr; the latest was in February 2020.

The peers of Harshamitra Oncology by revenue are Erode Cancer Centre Private Limited, Bridge Gap Lifesciences Private Limited, Karkinos Healthcare North East Private Limited, Babina Healthcare Private Limited, all in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities).

Govindaraj Ganesan was appointed as Managing Director on 30 May 2014. Sasipriya Ponniah was appointed as Managing Director on 30 May 2014.

Harshamitra Oncology can be reached through the website hopltrichy.com. Its registered office is in Tiruchirappalli, Tamil Nadu, India.

The registered office of Harshamitra Oncology is at 1014A Mathur Panchayat Road Junction, NH 45 B Trichy – Madurai Highway, Tiruchirappalli, Tamil Nadu, India – 620012.

Harshamitra Oncology operates in the healthcare industry, in the oncology clinics and cancer treatment segment.